• Guideline Summary
  • NGC:009318
  • 1996 (revised 2012 Dec 18)

Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.

  • Guideline Summary
  • NGC:008822
  • 2011 Jul 7 (reaffirmed 2016 Oct 31)

Management of a suspicious adnexal mass.

  • Guideline Summary
  • NGC:006287
  • 1999 Sep (revised 2008 Jan; reaffirmed 2012)

Elective and risk-reducing salpingo-oophorectomy.

  • Guideline Summary
  • NGC:010253
  • 2010 Jul (revised 2013 Apr)

Epithelial ovarian, fallopian tube, and primary peritoneal cancer.

  • Guideline Summary
  • NGC:010263
  • 2012 Apr (revised 2013 Apr)

Ovarian germ cell tumours.

  • Guideline Summary
  • NGC:010026
  • 2006 Jun 20 (revised 2013 Jul 1)

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

  • Guideline Summary
  • NGC:009786
  • 2004 Jan (revised 2013 Mar)

Long term follow up of survivors of childhood cancer. A national clinical guideline.

  • Guideline Summary
  • NGC:010742
  • 2005 Jun (revised 2015 Jun 23)

Suspected cancer: recognition and referral.

  • Guideline Summary
  • NGC:009119
  • 2003 Sep (revised 2012 Jul)

Nutrition and physical activity guidelines for cancer survivors.

  • Guideline Summary
  • NGC:010258
  • 2012 Jan (revised 2014 Jan)

Management of febrile neutropenia in adult cancer patients.

  • Guideline Summary
  • NGC:010053
  • 2012 Sep

Cancer and contraception.

  • Guideline Summary
  • NGC:009736
  • 2007 Jun (revised 2013 Apr)

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

  • Guideline Summary
  • NGC:009255
  • 1996 (revised 2012)

ACR Appropriateness Criteria® ovarian cancer screening.

  • Guideline Summary
  • NGC:010998
  • 2016 Apr 27

Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer.

  • Guideline Summary
  • NGC:009894
  • 2013 May

Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer.

  • Guideline Summary
  • NGC:009893
  • 2013 May

Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer.